Price Estimate, page-134

First 134 Last

Share
Profile

Follow
Bayswaterguy

1,737 Posts.

106

21/06/18

14:09

Post #: 33858435
Share

Originally posted by Tomasp ↑

The LT people here will know I've always been very supportive of QBL and have been a holder for nearly 2 years (buy-in at 1.85c).

To be honest, after the 6 weeks trading halt, I'm a little underwhelmed with the announcement - and really don't like the dilution to 3 billion shares. This means, any significant gain in the company, any positive operational steps taken are now watered down by almost double the number of shares outstanding. Over 1 billion shares outstanding I thought to be a bit high, but to me 3 billion makes me uncomfortable.

Every time the company issues more shares to acquire something, our own holdings get diluted - and we ultimately pay for this with lower potential SP. Why doesn't the company just focus on making headway within the business, rather than 'buying growth'.

I don't know what I was expecting with this ANN, but after seeing it yesterday left me in a state of flux. Whilst I've historically been very positive about the company, this latest ANN has introduced some worry into my thoughts...

Whilst I haven't sold a single QBL share yet, and thinking about the company LT I believe they are on the right path, the 3 bil dilution is disappointing.

*Note: I also noticed on some FB posts that QBL are posting their management is disappointed with today's performance. If I'm truly honest, I think the 3 bil dilution has a big role to play in people's lower than wanted reaction. The company can't just keep issuing new shares left, right and center....

Expand

When did QBL do their last capital raising?

QBL Price at posting: 5.6¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 74 more messages in this thread...

First 134 Last

Add CGB (ASX) to my watchlist

Price Estimate, page-134

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News